These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20417840)

  • 1. Should the Incretin hype be the same for older adults: Promise + cautions.
    Batsis JA; Porter Starr KN; Villareal DT
    J Am Geriatr Soc; 2024 Jul; 72(7):2266-2268. PubMed ID: 38393783
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes.
    DeFronzo RA; Eldor R; Abdul-Ghani M
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S127-38. PubMed ID: 23882037
    [No Abstract]   [Full Text] [Related]  

  • 3. Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE.
    Riddle MC
    Diabetes Care; 2024 Apr; 47(4):556-561. PubMed ID: 38527123
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Müller T
    MMW Fortschr Med; 2024 Jun; 166(10):11. PubMed ID: 38806900
    [No Abstract]   [Full Text] [Related]  

  • 5. The Consequences of Lowering Vitamin B12 With Chronic Metformin Therapy.
    Bell DSH
    Endocr Pract; 2023 Nov; 29(11):928-929. PubMed ID: 37625545
    [No Abstract]   [Full Text] [Related]  

  • 6. Don't hold the metformin: Enhancing inpatient diabetes education to encourage best practices in a public hospital.
    Sanders SF; Shen MS; Alaiev D; Knoll B; Cho HJ; Tsega S; Krouss M; Fagan I; Klinger A
    J Hosp Med; 2024 Jun; 19(6):551-556. PubMed ID: 38695331
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in incretin-based therapeutics for obesity.
    Rosenkilde MM
    Nat Rev Endocrinol; 2024 Feb; 20(2):67-68. PubMed ID: 38062121
    [No Abstract]   [Full Text] [Related]  

  • 8. DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature.
    Saini K; Sharma S; Khan Y
    Front Mol Biosci; 2023; 10():1130625. PubMed ID: 37287751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and clinical use of incretin-based therapies in patients with chronic kidney disease and type 2 diabetes.
    Scheen AJ
    Clin Pharmacokinet; 2015 Jan; 54(1):1-21. PubMed ID: 25331711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine.
    Tang HC; Chen CY
    Evid Based Complement Alternat Med; 2014; 2014():385120. PubMed ID: 24891870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational study on dipeptidyl peptidase-4 inhibitors: a real-life analysis on 360 patients from the ASL VCO territory in Italy.
    Saglietti G; Placentino G; Schellino A
    Clin Drug Investig; 2014 Jul; 34(7):513-9. PubMed ID: 24788571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions.
    Scheen AJ
    Clin Pharmacokinet; 2010 Sep; 49(9):573-88. PubMed ID: 20690781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin treatment for type 2 diabetes: when to start, which to use.
    Hamaty M
    Cleve Clin J Med; 2011 May; 78(5):332-42. PubMed ID: 21536829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incretin-mimetic drugs, an insulin alternative in type 2 diabetes].
    Fabreegas B
    Soins; 2008 Jun; (726):34-7. PubMed ID: 18697336
    [No Abstract]   [Full Text] [Related]  

  • 15. Add-on therapies to metformin for type 2 diabetes.
    Shomali M
    Expert Opin Pharmacother; 2011 Jan; 12(1):47-62. PubMed ID: 21142694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
    Halimi S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New medications for patients with type 2 diabetes].
    Meillet L
    Soins; 2014 Oct; (789):15-8. PubMed ID: 25518129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of incretin therapy to metformin in type 2 diabetes.
    Scheen AJ; Radermecker RP
    Lancet; 2010 Apr; 375(9724):1410-2. PubMed ID: 20417840
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.